AngioDynamics, Inc. (NASDAQ:ANGO) SVP Warren Nighan, Jr. Sells 4,060 Shares of Stock

AngioDynamics, Inc. (NASDAQ:ANGO) SVP Warren Nighan, Jr. sold 4,060 shares of the firm’s stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $12.31, for a total transaction of $49,978.60. Following the completion of the transaction, the senior vice president now directly owns 41,817 shares in the company, valued at $514,767.27. This trade represents a 8.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

AngioDynamics Price Performance

AngioDynamics stock opened at $12.43 on Friday. The firm has a market capitalization of $503.04 million, a price-to-earnings ratio of -2.21 and a beta of 0.59. The company’s 50 day simple moving average is $8.75 and its 200 day simple moving average is $7.65. AngioDynamics, Inc. has a fifty-two week low of $5.26 and a fifty-two week high of $13.13.

AngioDynamics (NASDAQ:ANGO) last announced its quarterly earnings results on Wednesday, January 8th. The medical instruments supplier reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.07. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The company had revenue of $72.90 million for the quarter, compared to analysts’ expectations of $70.93 million. During the same period last year, the firm posted ($0.05) earnings per share. The business’s quarterly revenue was down .1% compared to the same quarter last year. As a group, analysts predict that AngioDynamics, Inc. will post -0.36 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Quarry LP raised its position in shares of AngioDynamics by 75.1% during the second quarter. Quarry LP now owns 6,047 shares of the medical instruments supplier’s stock worth $37,000 after purchasing an additional 2,594 shares during the period. CWM LLC raised its holdings in AngioDynamics by 981.3% during the 3rd quarter. CWM LLC now owns 9,732 shares of the medical instruments supplier’s stock worth $76,000 after buying an additional 8,832 shares during the period. Mackenzie Financial Corp acquired a new stake in AngioDynamics during the 2nd quarter worth approximately $80,000. Wealth Enhancement Advisory Services LLC bought a new position in AngioDynamics in the third quarter valued at approximately $86,000. Finally, AE Wealth Management LLC acquired a new position in shares of AngioDynamics in the second quarter valued at approximately $87,000. 89.43% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ANGO. HC Wainwright raised their price objective on shares of AngioDynamics from $14.00 to $15.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Canaccord Genuity Group decreased their price objective on AngioDynamics from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Friday, October 4th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.